Who Paid My Doc
A Study of ALN-HSD in Healthy Adult Subjects and Adult Patients With Nonalcoholic Steatohepatitis (NASH)
Research payments
$1,312,908
Through program year 2024, $1,312,908 in research payments was reported against A Study of ALN-HSD in Healthy Adult Subjects and Adult Patients With Nonalcoholic Steatohepatitis (NASH), across 460 payments, paid by Alnylam Pharmaceuticals Inc..
- Paid by
- Alnylam Pharmaceuticals Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $157,744 | 73 |
| 2023 | Research | $419,679 | 136 |
| 2022 | Research | $643,776 | 220 |
| 2021 | Research | $91,708 | 31 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Gary Reiss Marrero, LA Named on 125 payments
- Juan Garza San Antonio, TX Named on 120 payments
- Donald Lazas Hermitage, TN Named on 24 payments
- Hernan Salazar San Antonio, TX Named on 24 payments
- Eric Lawitz San Antonio, TX Named on 19 payments
- Michael Herman Fleming Island, FL Named on 16 payments
- Eva-Maria Heurich Orlando, FL Named on 14 payments
- Paul Thuluvath Baltimore, MD Named on 12 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.